152 related articles for article (PubMed ID: 32929881)
1. In vitro methodology for medical device material thrombogenicity assessments: A use condition and bioanalytical proof-of-concept approach.
Wolf MF; Girdhar G; Anderson AA; Ubl SR; Thinamany S; Jeffers HN; DeRusha CE; Rodriguez-Fernandez J; Hoffmann S; Strief CA
J Biomed Mater Res B Appl Biomater; 2021 Mar; 109(3):358-376. PubMed ID: 32929881
[TBL] [Abstract][Full Text] [Related]
2. Platelet and leukocyte count assay for thrombogenicity screening of biomaterials and medical devices: Evaluation and improvement of ASTM F2888 test standard.
Lu Q; Nehrer JM; Li J; Jamiolkowski MA; Rinaldi JE; Malinauskas RA
J Biomed Mater Res B Appl Biomater; 2021 Dec; 109(12):2259-2267. PubMed ID: 34106517
[TBL] [Abstract][Full Text] [Related]
3. Comparison of animal and human blood for in vitro dynamic thrombogenicity testing of biomaterials.
Jamiolkowski MA; Patel M; Golding MD; Malinauskas RA; Lu Q
Artif Organs; 2022 Dec; 46(12):2400-2411. PubMed ID: 35866431
[TBL] [Abstract][Full Text] [Related]
4. Strategy for the hemocompatibility testing of microparticles.
Braune S; Basu S; Kratz K; Johansson JB; Reinthaler M; Lendlein A; Jung F
Clin Hemorheol Microcirc; 2016; 64(3):345-353. PubMed ID: 27886001
[TBL] [Abstract][Full Text] [Related]
5. Shear-induced platelet adherence and activation in an in-vitro dynamic multiwell-plate system.
Reinthaler M; Johansson JB; Braune S; Al-Hindwan HSA; Lendlein A; Jung F
Clin Hemorheol Microcirc; 2019; 71(2):183-191. PubMed ID: 30584128
[TBL] [Abstract][Full Text] [Related]
6. Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model.
Girdhar G; Andersen A; Pangerl E; Jahanbekam R; Ubl S; Nguyen K; Wainwright J; Wolf MF
J Biomed Mater Res A; 2018 Dec; 106(12):3195-3202. PubMed ID: 30242950
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Thrombogenicity Testing of Biomaterials.
Braune S; Latour RA; Reinthaler M; Landmesser U; Lendlein A; Jung F
Adv Healthc Mater; 2019 Nov; 8(21):e1900527. PubMed ID: 31612646
[TBL] [Abstract][Full Text] [Related]
8. The role of whole blood in thrombin generation in contact with various titanium surfaces.
Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
[TBL] [Abstract][Full Text] [Related]
9. Device thrombogenicity emulation: a novel methodology for optimizing the thromboresistance of cardiovascular devices.
Bluestein D; Girdhar G; Einav S; Slepian MJ
J Biomech; 2013 Jan; 46(2):338-44. PubMed ID: 23219278
[TBL] [Abstract][Full Text] [Related]
10. Reduced thrombogenicity of nitinol stents--in vitro evaluation of different surface modifications and coatings.
Tepe G; Schmehl J; Wendel HP; Schaffner S; Heller S; Gianotti M; Claussen CD; Duda SH
Biomaterials; 2006 Feb; 27(4):643-50. PubMed ID: 16095686
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of extracorporeal blood treatment. Selection of haemostatic parameters.
Lindhout T
Nephrol Dial Transplant; 1994; 9 Suppl 2():83-9. PubMed ID: 8065621
[TBL] [Abstract][Full Text] [Related]
12. Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.
Major TC; Handa H; Annich GM; Bartlett RH
J Biomater Appl; 2014 Oct; 29(4):479-501. PubMed ID: 24934500
[TBL] [Abstract][Full Text] [Related]
13. The scientific basis for selection of measures of thrombogenicity.
Lane DA; Bowry SK
Nephrol Dial Transplant; 1994; 9 Suppl 2():18-28. PubMed ID: 8065613
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo biocompatibility of avidin-agarose: a new device for direct adsorption of biotinylated antibodies from human whole blood.
Bosch T; Lennertz A; Duhr C; Fink E; Samtleben W
Artif Organs; 2000 Sep; 24(9):696-704. PubMed ID: 11012539
[TBL] [Abstract][Full Text] [Related]
15. The optimal incubation time for in vitro hemocompatibility testing: Assessment using polymer reference materials under pulsatile flow with physiological wall shear stress conditions.
Blok SLJ; van Oeveren W; Engels GE
J Biomed Mater Res B Appl Biomater; 2019 Oct; 107(7):2335-2342. PubMed ID: 30697956
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the thromboresistance of Dacron combined with various polyurethanes.
Leake DL; Cenni E; Cavedagna D; Stea S; Ciapetti G; Pizzoferrato A
Biomaterials; 1989 Sep; 10(7):441-4. PubMed ID: 2529915
[TBL] [Abstract][Full Text] [Related]
17. Circulatory loop design and components introduce artifacts impacting in vitro evaluation of ventricular assist device thrombogenicity: A call for caution.
Li M; Walk R; Roka-Moiia Y; Sheriff J; Bluestein D; Barth EJ; Slepian MJ
Artif Organs; 2020 Jun; 44(6):E226-E237. PubMed ID: 31876310
[TBL] [Abstract][Full Text] [Related]
18. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
19. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
[TBL] [Abstract][Full Text] [Related]
20. Hemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI).
Brockman KS; Kizhakkedathu JN; Santerre JP
Acta Biomater; 2017 Jan; 48():368-377. PubMed ID: 27818307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
